Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Chang-Won Hong"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review article
Molecular Biology
Comprehensive overview of the role of mitochondrial dysfunction in the pathogenesis of acute kidney ischemia-reperfusion injury: a narrative review
Min-Ji Kim, Chang Joo Oh, Chang-Won Hong, Jae-Han Jeon
J Yeungnam Med Sci. 2024;41(2):61-73.   Published online February 14, 2024
DOI: https://doi.org/10.12701/jyms.2023.01347
  • 11,304 View
  • 203 Download
  • 5 Web of Science
  • 6 Crossref
AbstractAbstract PDF
Acute kidney ischemia-reperfusion (IR) injury is a life-threatening condition that predisposes individuals to chronic kidney disease. Since the kidney is one of the most energy-demanding organs in the human body and mitochondria are the powerhouse of cells, mitochondrial dysfunction plays a central role in the pathogenesis of IR-induced acute kidney injury. Mitochondrial dysfunction causes a reduction in adenosine triphosphate production, loss of mitochondrial dynamics (represented by persistent fragmentation), and impaired mitophagy. Furthermore, the pathological accumulation of succinate resulting from fumarate reduction under oxygen deprivation (ischemia) in the reverse flux of the Krebs cycle can eventually lead to a burst of reactive oxygen species driven by reverse electron transfer during the reperfusion phase. Accumulating evidence indicates that improving mitochondrial function, biogenesis, and dynamics, and normalizing metabolic reprogramming within the mitochondria have the potential to preserve kidney function during IR injury and prevent progression to chronic kidney disease. In this review, we summarize recent advances in understanding the detrimental role of metabolic reprogramming and mitochondrial dysfunction in IR injury and explore potential therapeutic strategies for treating kidney IR injury.

Citations

Citations to this article as recorded by  
  • Mitochondrial function in intestinal ischemia-reperfusion injury: mechanisms and therapeutic perspectives
    Xuena Han, Zekun Lang, Xinghua Lv, Yang Xing, Min Hou, Zhiguo Tan, Yan Zhang, Yufang Leng
    Molecular Biology Reports.2025;[Epub]     CrossRef
  • Hyperoside mitigates amphotericin B-induced nephrotoxicity in HK-2 cells via bioenergetic and oxidative stress modulation
    Ekramy M. Elmorsy, Huda A. Al Doghaither, Ayat B. Al-Ghafari, Badriah Abdullah Hifni, Najlaa M.M. Jawad, Noor A. Hakim, Manal S. Fawzy, Nagwa M. Aly
    BMC Pharmacology and Toxicology.2025;[Epub]     CrossRef
  • The lactic dehydrogenase-to-albumin ratio predicts acute kidney injury in patients with intracerebral hemorrhage: a multicenter cohort study
    Taotao Dong, Yangchun Xiao, Xiang Yuan, Peng Wang, Chao You, Fang Fang, Yu Zhang
    Frontiers in Neurology.2025;[Epub]     CrossRef
  • ZNRF2 integrates ubiquitination-driven ferroptosis and mitochondrial quality control in renal ischemia–reperfusion injury
    Kangyu Wang, Yun Deng, Changhong Xu, Rui Yan, Hao Wang, Yalong Zhang, Jiangwei Man, Li Yang
    Biomedicine & Pharmacotherapy.2025; 192: 118584.     CrossRef
  • The role of gut microbiota–mitochondrial crosstalk in kidney disease: a bibliometric analysis
    Qin Hu, Hua Jin, Lan Hu, Xu Li
    International Urology and Nephrology.2025;[Epub]     CrossRef
  • Arfgef3 knockout ameliorates ischemia reperfusion-induced acute kidney injury via mitochondrial dysfunction alleviation in mice
    Longyu Wang, Lu Yao, Danshu Xie, Wei Ding
    Renal Failure.2025;[Epub]     CrossRef

JYMS : Journal of Yeungnam Medical Science
TOP